Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 12 announcements

Share price: ₹566.85
Market cap: ₹9,022 Cr
Revenue (annual): ₹829.0 Cr
Net profit (annual): ₹163.0 Cr
P/E (TTM): 51.2×Sector 57.8×
Promoter holding: 60.92%+0.00% QoQ
FII holding: 5.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Share Pledge 1 Promoter Buying (Off-Market) 1 Merger & Restructuring 1 Employee Stock Options 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Sep 2026 14:57 IST BSE

Merger & Restructuring

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare's board approved sale of 100% in Nueclear Healthcare to Trovera for ~₹141.40 Crore. The move exits radiology to refocus on core pathology business.

Value: ₹141.4 Cr
Execution: On or before November 30, 2026

Read the filing ↗